Abstract
BackgroundChemoradiation for cervical cancer patients is associated with considerable gastrointestinal toxicity. Intensity-modulated radiotherapy (IMRT) has demonstrated superiority in terms of target coverage and normal tissue sparing in comparison to conventional 3D planning in gynaecological malignancies. Whether IMRT in prone (PP) or supine position (SP) might be beneficial for cervical cancer patients remains partially unanswered.Methods10 patients on FIGO stage IB-III cervical cancer, 6 patients for definitive and 4 patients for adjuvant external beam pelvic RT, were planned in PP and SP using a 7-field IMRT technique. IMRT plans for PP and SP (mean dose, Dmean 50.4 Gy) were optimized in terms of PTV coverage (1st priority) and small bowel sparing (2nd priority). A comparison of DVH parameters for PTV, small bowel, bladder, and rectum was performed.ResultsThe comparison showed a similar PTV coverage of 95% of the prescribed dose and for target conformity in IMRT plans (PP, SP). PTV, rectum and bladder volumes were comparable for PP and SP. Significantly larger volumes of small bowel were found in PP (436 cc, + 35%, p = 0.01). PP decreased the volume of small bowel at 20-50.4 Gy (p < 0.05) and increased the rectum volumes covered by doses from 10-40 Gy (p < 0.01), the V50.4 was < 5% in both treatment positions. Bladder sparing was significant better at 50.4 Gy (p = 0.03) for PP.ConclusionIn this dosimetric study, we demonstrated that pelvic IMRT in prone position for patients with cervical cancer seems to be beneficial in reducing small bowel volume at doses ≥20 Gy while providing similar target coverage and target conformity. The use of frequent image guidance with KV (kilovolt) or MV (megavolt) computertomography can reduce set-up deviations, and treatment in prone position can be done with a higher set-up accuracy. Clinical outcome studies are needed to affirm lower toxicity.
Highlights
Chemoradiation for cervical cancer patients is associated with considerable gastrointestinal toxicity
Patients 10 patients with histological confirmed cervical cancer on FIGO stage IB1, IB2, IIB and IIIB were selected for this study. 6 patients were treated with definitive chemoradiation (FIGO stage: IB1 in 2 patients, IB2, IIA, IIB and IIIB each in one patient)
(megavolt) CT to provide the best possible reduction of set-up errors and treatment accuracy when using either position. In this dosimetric study, we demonstrated that pelvic Intensity-modulated radiotherapy (IMRT) in prone position on a belly board seems to be a useful tool to reduce small bowel volume at a dose ≥20 Gy whilst providing similar target coverage and target conformity for patients with cervical cancer
Summary
Chemoradiation for cervical cancer patients is associated with considerable gastrointestinal toxicity. Chemoradiation is the treatment of choice in locally advanced, lymph node positive and/or high-risk cervical cancer patients [1,2,3,4,5,6,7,8,9]. Patients 10 patients with histological confirmed cervical cancer on FIGO stage IB1, IB2, IIB and IIIB were selected for this study. 6 patients were treated with definitive chemoradiation (FIGO stage: IB1 in 2 patients, IB2, IIA, IIB and IIIB each in one patient) All of these patients underwent transperitoneal laparoscopic pelvic and paraaortic lymphadenectomy as described previously [36]. A chest X-ray and abdominal ultrasound was performed to exclude distant metastases
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have